Iovanace Biotherapeutics (IOVA) PT Lowered to $18 at Goldman Sachs

July 1, 2022 3:21 AM EDT Send to a Friend

Goldman Sachs analyst Madhu Kumar ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Iovanace Biotherapeutics (IOVA) PT Lowered to $18 at Goldman Sachs

Member Login

Free News Feed